Patents by Inventor Jingen XU

Jingen XU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD73-BINDING PROTEIN AND USE THEREOF
    Publication number: 20240067747
    Abstract: Provided is an isolated antigen-binding protein, which can specifically bind to CD73 and includes at least one CDR in a heavy chain variable region VH, wherein the region VH includes an amino acid sequence as represented by SEQ ID NO: 49.
    Type: Application
    Filed: January 12, 2022
    Publication date: February 29, 2024
    Inventors: Jingen XU, Xiangyang ZHU, Haijia YU, Xiaoyue WEI, Lili QU, Xiaochen REN
  • CD73 ANTIGEN-BINDING PROTEIN AND APPLICATION THEREOF
    Publication number: 20240026024
    Abstract: Provided is an isolated antigen-binding protein, capable of binding to CD73. The isolated antigen-binding protein contains HCDR3, and the HCDR3 comprises an amino acid sequences as shown in SEQ ID No.:3. Also provided are a preparation method for the antigen-binding protein, and an application of the antigen-binding protein.
    Type: Application
    Filed: December 10, 2021
    Publication date: January 25, 2024
    Inventors: Jingen XU, Xiangyang ZHU, Haijia YU, Xiaoyue WEI, Ling TONG, Shi CHEN
  • BISPECIFIC ANTIBODY AND USE THEREOF
    Publication number: 20240010730
    Abstract: Provided in the present application is a multispecific antibody, which includes a first targeting moiety capable of specifically binding to the TIGIT protein and a second targeting moiety capable of binding to a tumor-associated antigen, and the multispecific antibody can be used to treat a tumor. Further provided in the present application is the use of the multispecific antibody as a drug.
    Type: Application
    Filed: November 25, 2021
    Publication date: January 11, 2024
    Inventors: Xiangyang ZHU, Xiaopei CUI, Jingen XU, Haijia YU